Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 82: 1154-1162, 1997;
8750-7587/97 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mijailovich, S. M.
Right arrow Articles by Venegas, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mijailovich, S. M.
Right arrow Articles by Venegas, J. G.

Journal of Applied Physiology
Vol. 82, No. 4, pp. 1154-1162, April 1997
GAS EXCHANGE, MECHANICS, AND AIRWAYS

Effects of lung motion and tracer kinetics corrections on PET imaging of pulmonary function

Srboljub M. Mijailovich, Steven Treppo, and José G. Venegas

Department of Anesthesia, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts 02114

ABSTRACT
INTRODUCTION
GENERAL THEORY
METHODS
RESULTS
DISCUSSION
APPENDIX
ACKNOWLEDGEMENTS
FOOTNOTES
REFERENCES


ABSTRACT

Mijailovich, Srboljub, Steven Treppo, and José G. Venegas. Effects of lung motion and tracer kinetics corrections on PET imaging of pulmonary function. J. Appl. Physiol. 82(4): 1154-1162, 1997.---A method to assess the three-dimensional distribution of alveolar ventilation-perfusion ratio (VA/Q) by imaging the lungs with positron emission tomography (PET) during a constant-rate intravenous infusion of 13NN-labeled saline solution was developed by C. G. Rhodes, S. O. Valind, L. H. Brudin, P. E. Wollmer, T. Jones, P. D. Buckingham, and J. M. B. Hughes (J. Appl. Physiol. 66: 1896-1904 and 1905-1913, 1989). We have modified this methodology to obtain high-resolution, low-noise PET images of local VA/Q where lung motion artifact was eliminated by respiratory gating of image collection. In addition, we have refined and implemented the methods to assess local alveolar ventilation by imaging the washout of equilibrated 13NN and local perfusion by imaging the distribution of an intravenous bolus of 13NN-labeled saline solution during apnea. This paper experimentally evaluates the effect of the implemented modifications in mechanically ventilated and anesthetized dogs. We found that the lack of gating had no significant effect on the average recovered VA/Q, but the spatial heterogeneity [pixel-by-pixel coefficient of variation squared (CV2) = SD2/mean2] was underestimated by 14%. The lack of gating during the washout underestimated the average specific ventilation by 11% and decreased the corresponding CV2 by 50%.

regional lung function; respiratory gating; motion artifacts; nitrogen-13; positron emission tomography; alveolar ventilation; perfusion; ventilation-perfusion ratio


INTRODUCTION

LOCAL LUNG FUNCTION has been assessed by positron emission tomography (PET), from the noninvasive quantification of the spatial distribution of positron-emitting tracer isotopes.

Local alveolar gas volume (VA) and specific ventilation (sVA) have been assessed with PET from images collected during equilibrated rebreathing of 13NN tracer and during a subsequent washout of the tracer (13, 15). In those studies, correction for radioactive tracer decay was done by assuming constant tracer concentration during each image of the washout. Although this assumption leads to a good approximation for short-duration images, it can substantially underestimate sVA when long-duration images are collected during the washout.

Distribution of pulmonary blood flow has been measured by PET after intravenous bolus injection of radioactive-labeled microspheres (4) and intravenous injection of 15O-labeled water (7). Pulmonary blood flow measured from microspheres has the advantage that it is linearly related to measured activity over entire physiological range, but the long half-life of the labeled compounds is a disadvantage for making sequential complementary PET studies. 15O, in contrast, has a short half-life (2.05 min), but tissue activity is nonlinearly related to pulmonary blood flow and is strongly dependent on local water tissue content (7). Furthermore, because the transit time of the water through the lung is very short (<20 s), short-duration PET images have to be acquired, limiting the signal-to-noise ratio and/or resolution of the resulting images.

On the basis of the low solubility of 13NN in blood and tissues, Hales et al. (3) measured regional perfusion using a planar positron camera by imaging the lungs after an intravenous bolus injection of 13NN-labeled saline during apnea. The validity of this method rests on the assumption that, on arriving to the pulmonary capillary vessels, most of the tracer gas migrates to alveolar spaces where it remains during imaging. Although this technique overcomes the problems of 15O and radioactively labeled microspheres, the extent to which the alveolar tracer concentration during imaging changes (because of mixing between adjacent regions or readsorption of the 13NN by the capillary blood) has not been quantified.

Rhodes and co-workers (1, 2, 5, 6, 11) pioneered the tomographic measurements of alveolar ventilation perfusion ratio (VA/Q) during a constant infusion (CI) of 13NN in saline solution by using PET. Possible shortcomings of this method are as follows: the spatial averaging created by breathing motion of the lungs, the level of noise when imaging at high spatial resolution, the need to include the right ventricle in the imaged cross section, and the inaccuracies caused to partial volume effects.

We have refined the methods of Venegas et al. (14, 15), Hales et al. (3), and Rhodes et al. (1, 2, 5, 6, 11) to assess independently and at high resolution local VA from the washout of equilibrated 13NN, local perfusion (Q) from the distribution of an intravenous bolus of 13NN-labeled saline solution, and VA/Q by using CI technique, respectively. This paper describes in detail these methodologies and evaluates experimentally these refinements in mechanically ventilated dogs.

Glossary

A(t) Instantaneous tracer activity per unit mass at time t, in µCi/g
A0 Tracer activity per unit mass at a reference time (e.g., start of imaging), in µCi/g
ANN Tracer activity per unit mass of 13NN at the beginning of imaging, in µCi/g
ACO Tracer activity per unit mass of 11CO at the beginning of imaging, in µCi/g
Cpa(t), Cpv(t) Instantaneous tracer mass concentration in arterial and venous blood, respectively, in g/ml
CA(t) Instantaneous tracer mass concentration in alveoli, in g/ml
CA0 Mass tracer concentration of the gas during lung equilibration, in g/ml
CCO Mass tracer concentration of 11CO in blood, in g/ml
CCO1, CCO2 Mass tracer concentration of 11CO in blood at the beginning and at the end of the blood volume imaging, in g/ml
f Breathing frequency, breaths/min
fa Fraction of arterial pulmonary blood in the blood volume image (assumed to be equal to 0.42)
fCI Decay correction factor of the CI image to the reference time at the start of the image collection
fb Decay correction factor of the blood volume image to the reference time at the start of the image collection
fVA Decay correction factor of the gas volume content image to the reference time at the start of the image collection
fV Decay correction factor of the gas volume content image to the reference time at the start of the washout image collection
flambda Factor to account for tracer removal by pulmonary blood
fgated Correction factor that fills gaps during gated image collection
Kcam Calibration factor of the camera, in counts · µCi-1 · s-1
nb(t) Instantaneous voxel count rate registered by PET at time t, in counts · voxel-1 · s-1
np The ideal plateau tracer voxel count rate of a perfusion image that would have been reached in the absence of tracer kinetics, in counts/s
 &qdot;i Flow rate of the bolus of 13NN-labeled saline solution infused into the right atrium, in ml/min
 Q Regional perfusion, in ml · min-1 · cm-3 thorax
sVA = VA/VA Specific ventilation of the alveolar gas volume element, in l/min
S = 1S + 2S Total no. of counts in a voxel of an ungated image, in counts/voxel
2S Total no. of counts in a voxel of a gated image, in counts/voxel
Sb Total no. of counts in a voxel of the blood volume image, in counts/voxel
Sbn Voxel counts originating from arterial blood that are normalized to the CI image, in counts/voxel
SCI Total number of counts in a voxel of the CI image, in counts/voxel
SQ Total no. of counts in a voxel of the blood flow image, in counts/voxel
SR Total no. of counts in a voxel of the blood flow image that includes the tracer arrival period and the rise of count rate period, in counts/voxel
SVA Total number of counts in a voxel of the gas volume content image, in counts/voxel
Sw Total no. of counts in a voxel of the washout image, in counts/voxel
ti Infusion time of a bolus, in s
Tarr Arrival time of the tracer, measured from initiation of bolus infusion till the tracer arrival in a voxel, in s
Tb Collection time of blood volume image, in s
TCI Collection time of CI image, in s
TQ Collection time of the perfusion image, in s
TR Collection time of the initial bolus infusion image that includes Tarr and time of rising concentration, in s
TVA Collection time of the gas volume content scan, in s
Tw Collection time of the washout image scan, in s
Tw 0 Time from the beginning of collection of gas content image to the start of breathing of the tracer-free gas, in s
VA Gas volume content, in ml/cm3 thorax
Va, Vv Arterial and venous blood volume, respectively, in ml/cm3 thorax
 VA Alveolar ventilation, defined as tidal respiratory ventilation (VT · f ) minus dead-space ventilation (Vds · f ) (5), in ml · min-1 · cm-3 thorax
 Delta t Breathing period, in s
 Delta tgated Collection time of a gated image within a breathing period, in s
 lambda Blood-to-gas partition coefficient, in ml gas/ml blood
 tau d Tracer decay time constant, in s
 tau e Effective washout time constant, in s
 tau e b Effective ventilation time constant of the 11CO tracer from the pulmonary bloodstream, in s
 tau K Effective time constant of the tracer kinetics, in s
 tau Q Time constant of the tracer mass kinetics, in s
 tau w Washout time constant, in s
 tau V b Ventilation time constant of the 11CO tracer from the pulmonary bloodstream, in s


GENERAL THEORY

PET enables accurate, noninvasive measurement of the regional distribution of a positron-emitting isotope tracer within the lung in well-defined volume elements (voxels). The number of radioactive decay events detected per unit time (count rate) is proportional to the amount of the total radioactivity of the tracer in that voxel. In a typical voxel within the lung field, the tracer may be distributed among lung tissue and alveolar gas and pulmonary blood compartments.

Following the approach by Rhodes and co-workers (5), a lumped-parameter model of tracer kinetics in a voxel is derived under the following assumptions: 1) distributions of VA, Q, and VA/Q are assumed uniform within a voxel; 2) blood flow and ventilation are assumed to be continuous and invariant during the measurement period; 3) when the tracer is intravenously infused, it is assumed to be mixed with blood and thus distributed along the pulmonary arterial tree in proportion to Q; 4) tracer concentrations of end-capillary blood and alveolar gas are in equilibrium and distributed in accordance with the partition coefficient lambda .

A differential equation describing radioactive tracer kinetics within a voxel can be formulated from a tracer mass balance: the rate of change of tracer mass is equal to the rate of tracer influx of the tracer by the arterial perfusion (QCpa), minus the rate of tracer removal by ventilation (VACA) and by pulmonary venous outflow (lambda QCA)
V<SC>a</SC> <FR><NU>dC<SC>a</SC></NU><DE>d<IT>t</IT></DE></FR> = <A><AC>Q</AC><AC>˙</AC></A>Cpa − <A><AC>V</AC><AC>˙</AC></A><SC>a</SC>C<SC>a</SC> − &lgr;<A><AC>Q</AC><AC>˙</AC></A>C<SC>a</SC> (1)
where VA is the alveolar gas content per voxel volume, and Cpa and CA are the tracer mass concentration in arterial blood and in alveoli, respectively.

The specific activity of the tracer in a voxel can be expressed as the product of tracer mass concentration [C(t), in g/ml] and the tracer activity per unit mass [A(t), in µCi/g]. Because the tracer activity per unit mass decays exponentially with time, instantaneous tracer activity A(t), is
A(<IT>t</IT>) = A<SUB>0</SUB> <IT>e</IT><SUP>−<IT>t</IT>/&tgr;<SUB>d</SUB></SUP>

where A0 is tracer activity per unit mass at a reference time (e.g., start of imaging), t is time elapsed from that reference, and tau d is the tracer decay time constant. Neglecting the tracer activity within the tissue compartment, the number of counts per voxel S in an PET image is equal to the integral over collection time T of the total count rates from the alveolar and arterial and venous blood compartments
<IT>S</IT> = <IT>K</IT><SUB>cam</SUB> <LIM><OP>∫</OP><LL><IT>t</IT><SUB>0</SUB></LL><UL><IT>t</IT><SUB>0</SUB>+T</UL></LIM> [V<SC>a</SC>C<SC>a</SC>(<IT>t</IT>) + VabCpa(<IT>t</IT>) + VvCv(<IT>t</IT>)]
⋅ A<SUB>0</SUB><IT>e</IT><SUP>−<IT>t</IT>/&tgr;<SUB>d</SUB></SUP>d<IT>t</IT> (2)

where Cv(t), Vv, Cpa(t), and Va are the regional tracer mass concentration and volume of pulmonary venous and arterial blood, respectively; and Kcam is the calibration factor of the camera correlating total activity per cubic centimeter thorax, with a voxel rate of coincidence counts registered by the PET camera. Equations 1 and 2 are applied to different experimental conditions to assess VA, Q, VA, and VA/Q with PET.

Respiratory Gating

To minimize motion artifacts during breathing, image collection is gated in synchrony with the mechanically controlled breathing. A ventilatory frequency f is fixed at 12 breaths/min, with inspiratory time equal to 30% of the breathing period (Delta t). Triggered at the start of inhalation by the ventilator, the PET camera acquires two images of equal duration (2.48 s) and waits for a new trigger signal to repeat the cycle, averaging the data over a predetermined total collection time. The first of these images covers inhalation and the early part of exhalation, whereas the second image covers the last part of exhalation when the lung motion is small and its volume is essentially at resting functional residual capacity (FRC). The second image is referred to as "gated," with a number of counts per voxel (2S). Images created by adding the two images to cover most of the entire breathing cycle (4.96 of 5.0 s) are referred to as "ungated" images, with a number of counts per voxel S = 1S + 2S.

Assessment of VA Content and sVA

The subject is ventilated with 13NN-labeled gas in a closed breathing circuit until equilibration of the tracer gas among lung gas spaces and rebreathing circuit is achieved. Gated images of VA content, with voxel counts 1SVA and 2SVA, are then collected for a total collection time TVA. A sample of rebreathing gas is obtained during this period to assess its specific activity A(t)CA(t). Subsequently, the breathing circuit is opened for ventilation with the tracer-free gas (at the time Tw 0 after the beginning of collection of the SVA image) and the gated washout images, with voxel counts 1Sw and 2Sw, are collected during a total collection time of Tw (Fig. 1). The beginning of collection of the washout image used in the exponential approximation starts at Tw 0.
Fig. 1. Schematic semilog plot of voxel count rate [n(t)] vs. time (solid line) and gated image collection intervals (solid bars) during lung volume (SVAi) and washout (Swi) imaging protocols. Decay correction values np(t) vs. time (dotted line) and decay slopes are indicated: tau -1d, radioactive decay slope; &tgr;<SUP>−1</SUP><SUB><A><AC>V</AC><AC>·</AC></A></SUB>, ventilation decay slope; tau -1e, effective decay slope. Tw0 is time from the beginning of collection of gas-content image to start of breathing of tracer-free gas.
[View Larger Version of this Image (23K GIF file)]

VA content. Because of the low solubility of 13NN in blood and tissue, during steady state the voxel activity of rebreathing gas is proportional to the local VA content. Thus neglecting the effect of the adsorption of tracer by the blood (lambda QCA term in Eq. 1), the average VA per voxel can be estimated as
V<SC>a</SC> = <FR><NU><IT>S</IT><SUB>V<SC>a</SC></SUB> <IT>f</IT><SUB>V<SC>a</SC></SUB> <IT>f</IT><SUB>gated</SUB></NU><DE><IT>K</IT><SUB>cam</SUB>C<SC>a</SC><SUB>0</SUB>A<SUB>0</SUB>T<SUB>V<SC>a</SC></SUB></DE></FR> (3)

where SVA is either 1SVA + 2SVA (total counts/voxel of the ungated VA) or 2SVA (total counts/voxel of gated VA image); CA0 is the mass tracer concentration of the rebreathed gas; A0 is activity per unit mass of breathing gas at the start of image collection; fVA is decay correction factor to the start of the image collection (see Appendix, Eq. A1); TVA is collection time of the lung volume scan; Kcam is a calibration factor of the camera; and fgated is either 1 for ungated images or ~2 for gated images (see Eq. A3).

Alveolar sVA. Washout images reflect a simultaneous exponential decay in mass concentration of tracer (represented by a time constant tau w) and an exponential decay in radioactivity of the tracer (represented by decay time constant tau d) (Fig. 1). It can be shown that the total counts per voxel collected during a washout (Sw) are a function of an effective exponential time constant (tau e) that combines the time constants of these two exponential decays: tau e = (1/tau w + 1/tau d)-1. The value of tau e can be calculated from Eq. A5a (derived in Appendix) as
&tgr;<SUB>e</SUB> = <FR><NU><IT>S</IT><SUB>w</SUB></NU><DE><IT>S</IT><SUB>V<SC>a</SC></SUB> <IT>f</IT><SUB>V</SUB></DE></FR> ⋅ <FR><NU>T<SUB>V<SC>a</SC></SUB></NU><DE>(1 − <IT>e</IT><SUP>−T<SUB>w</SUB>/&tgr;<SUB>e</SUB></SUP>)</DE></FR> (4)
where fV = fVA · e-Tw 0/tau d is a decay correction factor for the VA content image to a reference time at the initiation of the washout.

The sVA, defined as the inverse of tau w, becomes
s<A><AC>V</AC><AC>˙</AC></A><SC>a</SC> = <FR><NU>1</NU><DE>&tgr;<SUB>w</SUB></DE></FR> = <FENCE><FR><NU>1</NU><DE>&tgr;<SUB>e</SUB></DE></FR> − <FR><NU>1</NU><DE>&tgr;<SUB>d</SUB></DE></FR></FENCE> <FENCE><IT>f</IT><SUB>&lgr;</SUB></FENCE> (5)
where flambda  = 1 + lambda (Q/VA) is a factor to account for tracer removal by pulmonary blood assumed to be 1 for normal lungs.

Assessment of Q

Starting with a tracer-free lung, the ventilator is turned off at end exhalation, and a bolus of 13NN-labeled saline solution is immediately infused into the right atrium at a constant flow rate &qdot;i for infusion time ti (Fig. 2). A sample of the infusate is then collected to assess its specific activity (A0Ci) in a cross-calibrated well counter. Simultaneously with the start of infusion, a series of sequential images is collected while the subject remains in apnea.
Fig. 2. Schematic plot of idealized voxel count rate n(t) vs. time (solid line) and count rate corrected for tracer kinetics (dashed line) during perfusion imaging protocol. SR, SQ1 and SQ2 are total nos. of counts per voxel of 3 perfusion images. Delta SR1, Delta SR2, and Delta SQ (hatched area) are corrections for tracer kinetics. TR is collection time of the image that covers rising time of alveolar concentration and must be larger than sum of arrival time Tarr and bolus infusion ti. TQ is total collection time of perfusion image.
[View Larger Version of this Image (17K GIF file)]

Because of the low-solubility 13NN in blood and tissues, most of the tracer diffuses into alveolar gas at first pass, and the alveolar distribution of 13NN approximates Q (3). An idealized time course of alveolar tracer concentration in a voxel involves an arrival time Tarr, a period of linear increase in concentration during infusion ti, and a period where CA remains at a constant plateau value (Fig. 2). In reality, the tracer may diffuse to neighboring regions and/or may be readsorbed by the pulmonary circulation. To assess and correct for these possible sources of error, a sequence of image collection was designed, consisting of a first image including the infusion and increasing concentration phases (with counts SR and duration TR >=  ti + Tarr) and two additional images during the plateau phase (with voxel counts S<SUB><A><AC>Q</AC><AC>·</AC></A><SUB>1</SUB></SUB> and S<SUB><A><AC>Q</AC><AC>·</AC></A><SUB>2</SUB></SUB> and duration T<SUB><A><AC>Q</AC><AC>·</AC></A></SUB> /2 each) (Fig. 2).

Assuming that during the plateau phase the alveolar tracer activity changes exponentially, its equivalent time constant (tau K), which incorporates radioactive tracer decay tau d and the tracer removal tau Q, can be derived as a function of SQ1 and SQ2
&tgr;<SUB>K</SUB> = <FR><NU>&tgr;<SUB><A><AC>Q</AC><AC>˙</AC></A></SUB>&tgr; <SUB>d</SUB></NU><DE>&tgr;<SUB><A><AC>Q</AC><AC>˙</AC></A></SUB> + &tgr;<SUB>d</SUB></DE></FR> = <FR><NU><FENCE><FR><NU>T<SUB><A><AC>Q</AC><AC>˙</AC></A></SUB></NU><DE>2</DE></FR></FENCE></NU><DE>ln (<IT>S</IT><SUB><A><AC>Q</AC><AC>˙</AC></A> <SUB>1</SUB></SUB>/<IT>S</IT><SUB><A><AC>Q</AC><AC>˙</AC></A><SUB>2</SUB></SUB> )</DE></FR> (6)

After correction for tracer kinetics and tracer radioactive decay, the voxel values for Q (in ml/cm3) can then be calculated as
<A><AC>Q</AC><AC>˙</AC></A> = <FR><NU><IT>n</IT><SUB>p</SUB></NU><DE>CpaA<SUB>0</SUB><IT>K</IT><SUB>cam</SUB></DE></FR> (7)

where
<IT>n</IT><SUB>p</SUB> = <FR><NU><IT>S</IT><SUB><A><AC>Q</AC><AC>·</AC></A><SUB>1</SUB></SUB> + <IT>S</IT><SUB><A><AC>Q</AC><AC>·</AC></A><SUB>2</SUB></SUB></NU><DE>&tgr;<SUB>k</SUB>(1 − <IT>e</IT><SUP>−T<SUB><A><AC>Q</AC><AC>·</AC></A></SUB> /&tgr;<SUB><SUB>K</SUB></SUB></SUP>)</DE></FR>

is the ideal plateau tracer count rate that would have been reached in the absence of local tracer loss and radioactive decay.

Assessment of VA/Q

Assuming that a steady-state concentration of the alveolar gas is achieved during a CI of 13NN-labeled saline, Eq. 1 yields to the expression for regional VA/Q ratio
<FR><NU><A><AC>V</AC><AC>˙</AC></A><SC>a</SC></NU><DE><A><AC>Q</AC><AC>˙</AC></A></DE></FR> = <FR><NU>Cpa</NU><DE>C<SC>a</SC></DE></FR> − &lgr; (8)

Our methodology to obtain the values of Cpa and CA with PET is as follows. During steady-state breathing with tracer-free gas, infusion of 13NN-labeled saline solution, with specific activity CCIA0, is initiated at a constant flow rate of 15 ml/min. With the start of infusion, a series of four sequential gated images are collected. Images acquired after a steady-state concentration is reached are summed into an image with total collection time TCI and voxel counts SCI. During the steady state, a sample of pulmonary arterial blood is collected to assess its specific activity decay corrected to the initiation of image collection (CpaA0). Alveolar tracer concentration CA is assessed from SCI, after subtracting the counts contributed by radioactivity of the local pulmonary arterial blood (Sbn).

To estimate Sbn, an additional blood volume scan is performed. Red blood cells are labeled by inhalation of 11C-labeled CO (11CO; half-life of 20 min) until the activity has reached a suitable steady-state count rate. After allowing enough time (10 min) for the tracer to wash away from the alveolar gas space, a gated image is collected, with voxel counts of 2Sb and collection time Tb. Blood samples are taken at the beginning and at the end of collection to asses the initial and final tracer specific activity. Sbn is obtained from the counts recorded in the gated blood volume image 2Sb (see Appendix, Eq. A12 for details), assuming that 40% of regional blood volume was arterial tree and thus labeled with 13NN during the CI protocol (6). CA is thus estimated as
C<SC>a</SC> = <FR><NU> <SUP>2</SUP>S<SUB>CI</SUB><IT>f</IT><SUB>gated</SUB><IT>f</IT><SUB>CI</SUB> − <IT>S</IT><SUB>bn</SUB></NU><DE>V<SC>a</SC>T<SUB>CI</SUB>CpaA<SUB>0</SUB><IT>K</IT><SUB>cam</SUB></DE></FR> (9)

where fCI is the decay correction factor of CI image to the reference time at the start of the image collection.

An ungated VA/Q image is derived from the ungated SCI and Sb images and by setting fgated = 1 in Eqs. 9 and A12.


METHODS

Animal Studies

Detailed experimental protocols, animal preparation, and image processing are described in an accompanying paper (9). Five mongrel dogs were studied in the prone position and five in the supine position. The animals were positioned within the PET camera to obtain an image of the transverse slice of the lungs with the greatest cross-sectional area.

Image Analysis

Images of VA, sVA, Q, and VA/Q were generated for gated and ungated conditions. These images were characterized in terms of mean voxel value and spatial heterogeneity defined as the pixel-by-pixel coefficient of variation (CV = SD/mean) of the voxel values within the lung field. The procedure to define the lung field is described in detail in the accompanying paper (9).

To exclude areas outside the lung field, the heart, and large blood vessels, we used the same mask for all analyzed images. We developed a master mask by using the following three-step iterative procedure. Voxels outside the lung field were eliminated by thresholding the CI image and refined until no extraneous points remained (mean threshold 33 ± 6% of the peak voxel value). A similar procedure was used to isolate the heart and large vessels from the blood volume (Vb) image (mean threshold 55 ± 5% of the peak voxel value) and subtracted from the lung field mask. Finally, this mask was further refined to exclude areas that heart and lungs share during imaging period because of heart motion (at most 2-3 voxels wide, where voxel size was 0.1925 × 0.1925 × 0.5 cm2).

Statistical Analysis

Values are means ± SE obtained from five measurements (5 prone or 5 supine dogs). Also, measured mean values and CV2 values were compared by using Student's paired t-test. Statistical significance was taken at P < 0.05 level.


RESULTS

Image Gating

PET images of regional VA, sVA, and VA/Q are all acquired during breathing. Because the imaging device remains stationary in space, these PET images can be expected to be affected by breathing in two distinct ways. First, there may be an underestimation of regional heterogeneity because of spatial averaging; and, second, the expansion of the lung parenchyma during breathing could result in a greater mean voxel gas content compared with that at FRC.

As expected, VA without gating was higher on average (10.5 and 5.7% for prone and supine positions, respectively) compared with VA measured during the last part of expiration. We have chosen to present results as CV2 rather than as the CV, because the contributions of different factors to heterogeneity such as nose or vertical gradients are additive only when expressed in terms of CV2. Reflecting the spatial averaging created by lung motion, the regional heterogeneity (CV2) of VA ungated was significantly lower compared with VA gated (16.9 and 12.2%, respectively) for prone and supine positions.

Gating created no significant differences in mean VA/Q values, either prone or supine (Table 1). In contrast, CV2 of VA/Q was significantly lower when measured without gating, compared with gating (16.4 and 12.3% decrease for prone and supine positions, respectively).

Table 1. Effect of gating on mean values and CV2 of VA, sVA, and VA/Q


Variable %Change of Mean
%Change of CV2
Prone Supine Prone Supine

VA  -10.5 ± 5.5   -5.7 ± 2.8* 16.9 ± 4.0  12.2 ± 2.5*
 VA/Q  -4.0 ± 3.3  0.8 ± 2.1  16.4 ± 3.3  12.3 ± 3.7*
sVA 9.1 ± 2.4  12.5 ± 4.5* 44.9 ± 5.3  55.4 ± 5.7*

Values are in %change of means ± SE and coefficient of variation (CV)2 ± SE between gated and ungated images [where % difference is defined as (1 - value from ungated image/value from gated image) × 100%]. VA, alveolar gas volume; VA/Q, ventilation-perfusion ratio; sVA, specific alveolar ventilation. Values were averaged over 5 measurements (5 supine or 5 prone dogs), and they were reported as significant (*) if P < 0.05 based on all 10 animals taken as 1 group to compare gated vs. ungated.

Mean values of gated sVA were significantly higher (9.1% increase in prone and 12.5% in supine positions) than those for ungated sVA, and the CV2 values for gated sVA were also significantly higher than these for ungated sVA (44.9% increase in prone and 55.4% in supine animals) (Table 1).

Tracer Decay Correction Method for Washout Images

Correction for radioactive tracer decay in PET is generally carried out for each image by assuming that the tracer concentration is constant during the image-collection washout maneuver. The error incurred by such an assumption during a washout maneuver depends on the ratio of tracer washout time constant tau w to the radioactive decay time constant tau d and the image collection time. This error is greatest for rapid washouts and increases dramatically with increasing collection times. In our 3-min washout images with typical tau w of 20 s, this error would have been ~8%.

Blood Contribution to Local Activity Distribution During CI

The estimated contribution of tracer activity in pulmonary arterial blood to total activity per voxel during CI of 13NN saline after masking heart and large blood vessels (9) was 15.9 ± 2.1% for prone and 12.8 ± 2.2% for supine positions. Correction for the contribution of tracer in pulmonary blood did not significantly change the CV2 (i.e., increase of 5.7 ± 5.3% in prone and decrease of 3.3 ± 4.3% in supine positions).

Tracer Kinetics During Q Imaging

In healthy dog lungs, the correction of the Q image for time variations in local tracer concentration during the imaging increased the mean values of Q by 13.7 ± 4.0% in supine and by 7.9 ± 4.0% in prone positions. The CV2 of Q was decreased by 13.5 ± 6.5% in supine and by 5.5 ± 4.2% in prone positions by this correction.


DISCUSSION

We implemented methodologies for assessing the local distribution of VA, Q, VA, and VA/Q with PET including the following enhancements: 1) elimination of lung motion artifact by respiratory gating; 2) implementation of a proper correction for radioactive tracer decay during washouts; 3) implementation of a robust method of correction for the contribution of activity in pulmonary arterial blood to the CI images; and 4) correction for the effect of temporal changes in tracer concentration during collection of Q images. These corrections affected the mean value and/or the CV2 of the VA, Q, VA, and VA/Q images in different degrees.

The theoretical model used to interpret and analyze the PET images (from mechanically ventilated dogs) during CI (5) is based on several assumptions and simplifications. Among them are that the distributions of VA, Q, and VA/Q are uniform within a pixel; that the tracer is well mixed with the blood during infusion; and that the lungs are ventilated by continuous rather than a tidal ventilation. Rhodes and co-workers (5) have discussed in detail the shortcomings and validity of the model. We are limiting this discussion to areas affected by our modifications of the technique.

Effect of Gating

We found that all images acquired with gating had higher spatial heterogeneity (CV2) than those acquired without gating (Table 1). This finding was consistent with the expected spatial averaging effect caused by lung motion during breathing, which should be reduced by imaging the lungs during end exhalation only. However, the average increase in CV2 of the VA and VA/Q images by gating was not greater than 17%. This suggests that, in normal animals breathing with a total volume as large as 20 ml/kg, interregional differences are relatively small at the length scale of the breathing motion. In our study, we used low respiratory frequency (~12 breaths/min) and short inspiratory times to ensure that VA was close to FRC during the second (gated) image collection. Thus, to maintain normocapnea, total volume had to be relatively large (22 ml/kg). Given that our total volume was much higher than that of spontaneous breathing in humans, the fact that the effect of gating on VA/Q was so small suggests that motion artifacts must have been even smaller than the data reported by Rhodes et al. (6). A much greater (approx 50%) increase in the CV2 of sVA uncovered by gated imaging suggests that a significant component of heterogeneity in ventilation must occur at the length scales comparable to lung motion during breathing.

Aside from spatial averaging of breathing motion, other mechanisms could have also contributed to the lower CV2 seen without gating. Gating reduced by one-half the total imaging time and reduced the total number of counts per voxel, thus increasing the contribution of statistical noise to the heterogeneity of the gated images (12). The primary images of CI and VA, used to generate VA/Q, had very high counts (>5,000 counts/resolution element) in which noise was estimated to contribute <2% to the corresponding CV2. Thus, we are confident that noise was not responsible for the increased heterogeneity of the VA/Q images seen with gating. In contrast, the average contribution of noise to the CV2 of sVA with gating was as much as 20%. Subtraction of the contribution of noise from both gated and ungated sVA images decreased the corresponding CV2 but it did not appreciably change the percent increase in CV2 uncovered by gating. Therefore, the increased noise in sVA images between gated and ungated cannot explain the increase in CV2.

Analysis of Washouts

In the past (12-14), we have assessed sVA with the 13NN-washout technique by using the exponential approximation. Analysis included correction for radioactive tracer that assumed a constant tracer concentration during each image collected. The error induced by this assumption is small when several short images are collected, and each of these images is individually corrected for radioactive decay before summation for the calculation of sVA. However, the error induced may become significant when, as in our study, long (60-s) washout images are collected. This source of error was eliminated by measuring an equivalent time constant that combined radioactive decay and tracer washout. Because the radioactive decay time constant of 13NN is known, the tracer washout time constant can be readily solved by using Eq. 5.

Contribution of Activity in Arterial Blood to CI Images

In addition to the activity originating from alveolar spaces, images acquired during the CI protocol include a contribution from the activity in pulmonary blood. To correct for this contribution, Rhodes et al. (6) used a method that relied on a measurement of pulmonary arterial blood specific activity from an area of interest defined in the right ventricle. Because of partial volume effects, this measurement becomes quite unreliable in small animals. In our study, we obtained samples of pulmonary arterial blood during CI and of systemic blood during the blood volume scan and we measured their specific activity in a well counter previously cross calibrated with the PET camera to eliminate this source of error. We found that neglecting to include the effect of pulmonary blood activity resulted in an average underestimation of VA/Q of ~15% in normal lungs. This value is in good agreement with the number reported for humans by Rhodes et al. (6). Correction for pulmonary arterial blood activity left the heterogeneity of VA/Q relatively unchanged.

Tracer Kinetics During Q Imaging

We developed and implemented an algorithm that estimated and corrected for local changes in tracer concentration during the imaging period. The algorithm also estimates and uses the tracer arrival time to each voxel, a factor critical only for regions with rapid drops in tracer concentration.

One could expect that interregional mixing by diffusion or cardiogenic oscillations could have decreased the heterogeneity in Q recovered by our technique. However, if that was the case, one would have expected that the tracer kinetics correction (which follows and corrects for dynamic changes in local concentration) would have increased the heterogeneity of the Q image. The fact that tracer kinetics correction in normal lungs was so small strongly supports the concept that interregional mixing during measurement period, if present, occurred at length scales lower than the spatial resolution length of our images. Although the overall correction was rather small in the normal dogs, our preliminary studies showed that it could be extremely important in atelectatic lungs (8).

In summary, we have refined and successfully implemented imaging methodologies to assess VA, sVA, Q, and VA/Q at high spatial resolution. The effects of these refinements are small in normal animals but could be much greater in diseased lungs.


ACKNOWLEDGEMENTS

This work was supported by the National Heart, Lung, and Blood Institute Grant HL-38267.


FOOTNOTES

Address for reprint requests: J. Venegas, Dept. of Anesthesia, Room 255 (CLN-2), Massachusetts General Hospital, Fruit St., Boston, MA 02114.

Received 22 March, 1995; accepted in final form 12 November 1996.


APPENDIX

Gas Volume Image

After a sufficient time for equilibration, the concentration of the 13NN-labeled tracer gas in a closed breathing circuit is approximately constant. Because there is no perfusion of tracer (Cpa = 0), and neglecting adsorption of the tracer by the blood (lambda Q approx  0), the number of counts per voxel in SVA can be calculated by integrating Eq. 2
<IT>S</IT><SUB>V<SC>a</SC></SUB> = <IT>K</IT><SUB>cam</SUB>V<SC>a</SC>C<SC>a</SC><SUB>0</SUB>A<SUB>0</SUB>T<SUB>V<SC>a</SC></SUB> /<IT>f</IT><SUB>V<SC>a</SC></SUB> (A1)
where

<IT>f</IT><SUB>V<SC>a</SC></SUB> = (T<SUB>V<SC>a</SC></SUB> /&tgr;<SUB>d</SUB>)/(1 −<IT>e</IT><SUP>−T<SUB>V<SC>a</SC></SUB> /&tgr;<SUB>d</SUB></SUP>)
is a radioactive decay correction factor.

Gating Correction Factor for VA

If one integrates instantaneous tracer activity over acquisition time Delta tg for each breath, the total number of counts 2SVA is equal to sum of these integrals during the collection time TVA. Because net collection time per breath is reduced to a fraction of a breathing period, 2SVA should be multiplied by a correction factor fgated to account for the reduction in collection time
<IT>f</IT><SUB>gated</SUB> = <FR><NU><IT>e</IT><SUP>(&Dgr;<IT>t</IT> − &Dgr;<IT>t</IT><SUB>g</SUB>)/&tgr;<SUB>d</SUB></SUP>(1 − <IT>e</IT><SUP>−&Dgr;<IT>t</IT>/&tgr;<SUB>d</SUB></SUP>)</NU><DE>(1 − <IT>e</IT><SUP>−&Dgr;<IT>t</IT><SUB>g</SUB>/&tgr;<SUB>d</SUB></SUP>)</DE></FR> (A2)
where Delta t is breathing period; Delta tg is the collection time of the gated image, and then VA can be calculated from Eq. 3.

In the case where the breathing period is much shorter than the time constant of radioactive decay of the tracer, the correction factor is approximately equal to
<IT>f</IT><SUB>gated</SUB> ≈ <FR><NU>&Dgr;<IT>t</IT></NU><DE>&Dgr;<IT>t</IT><SUB>g</SUB></DE></FR> (A3)

Alveolar sVA

After collection of the VA image, the breathing circuit is open to tracer-free gas. A washout image is collected as the tracer is washed out. The concentration of the radioactive tracer is obtained from Eq. 1, by setting the Cpa to zero and assuming that the mass concentration of the radioactive tracer at the beginning of the image collection is CA0.
C<SC>a</SC>(<IT>t</IT>) = C<SC>a</SC><SUB>0</SUB><IT>e</IT><SUP>−s<A><AC>V</AC><AC>˙</AC></A><SC>a</SC><IT>f</IT><SUB>&lgr;</SUB><IT>t</IT></SUP> (A4)
Where CA(t) is the mass concentration of the tracer in the alveoli; sVA = VA/VA is the specific ventilation; and flambda = 1 + lambda Q/VA is a blood adsorption correction factor. The number of counts in the washout image according to Eq. 2 is
<IT>S</IT><SUB>w</SUB> = <IT>K</IT><SUB>cam</SUB>V<SC>a</SC>C<SC>a</SC><SUB>0</SUB>A<SUB>0</SUB><IT>e</IT><SUP>−T<SUB>w 0</SUB>/&tgr;<SUB>d</SUB></SUP>&tgr;<SUB>e</SUB>(1 − <IT>e</IT><SUP>−T<SUB>w</SUB>/&tgr;<SUB>e</SUB></SUP>) (A5)
where tau e is an effective time constant such that
<FR><NU>1</NU><DE>&tgr;<SUB>e</SUB></DE></FR> = <FR><NU>1</NU><DE>&tgr;<SUB>w</SUB></DE></FR> + <FR><NU>1</NU><DE>&tgr;<SUB>d</SUB></DE></FR>
and
<FR><NU>1</NU><DE>&tgr;<SUB>w</SUB></DE></FR> = s<A><AC>V</AC><AC>˙</AC></A><SC>a</SC><IT>f</IT><SUB>&lgr;</SUB>
Note that A0e-Tw 0 /tau d is tracer activity per unit mass at the beginning of collection of washout image. A ratio of Eqs. A1 and A5 yields to an implicit function of tau e that can be solved iteratively
&tgr;<SUB>e</SUB>(1 − <IT>e</IT><SUP>−T<SUB>w</SUB>/&tgr;<SUB>e</SUB></SUP>) − <FR><NU>S<SUB>w</SUB>T<SUB>V<SC>a</SC></SUB></NU><DE><IT>f</IT><SUB>V</SUB> <IT>S</IT><SUB>V<SC>a</SC></SUB></DE></FR> = 0 (A5a)
where fV = fVAe-Tw 0/tau d, is a decay correction factor of SVA image to the beginning of breathing tracer-free gas.

Alveolar Tracer Content During Steady-State CI

During the CI protocol, the influx of tracer into the alveolar space is constant and equal to Q · Cpa, and the lungs are being ventilated with tracer-free gas. The solution of the differential Eq. 1 under these conditions becomes
C<SC>a</SC>(<IT>t</IT>) = <FR><NU>Cpa<A><AC>Q</AC><AC>˙</AC></A></NU><DE><A><AC>V</AC><AC>˙</AC></A><SC>a</SC><IT>f</IT><SUB>&lgr;</SUB></DE></FR> (1 − <IT>e</IT><SUP>−s<A><AC>V</AC><AC>˙</AC></A><SC>a</SC><IT>f</IT> <SUB>&lgr;</SUB><IT>t</IT></SUP>) (A6)
where flambda is defined in Eq. A4.

At steady-state (sVA flambda t >>  1), Eq. A6 simplifies to
C<SC>a</SC>(<IT>t</IT>) = <FR><NU>Cpa<A><AC>Q</AC><AC>˙</AC></A></NU><DE><A><AC>V</AC><AC>˙</AC></A><SC>a</SC><IT>f</IT><SUB>&lgr;</SUB></DE></FR> (A7)
and solving Eq. 2 yields the number of counts of the CI image
<IT>S</IT><SUB>CI</SUB> = <IT>K</IT><SUB>cam</SUB> <FENCE>Cpa<A><AC>Q</AC><AC>˙</AC></A> <FR><NU>V<SC>a</SC></NU><DE><A><AC>V</AC><AC>˙</AC></A><SC>a</SC><IT>f</IT><SUB>&lgr;</SUB></DE></FR> + VaCpa</FENCE> (1 − <IT>e</IT><SUP>−T<SUB>CI</SUB>/&tgr;<SUB>d</SUB></SUP>)T<SUB>CI</SUB> /<IT>f</IT><SUB>CI</SUB> (A8)
Here Va and Cpa are the pulmonary arterial blood volume and the radioactive tracer concentration, respectively, and fCI = (TCI/tau d)/(1 - e-TCI/tau d) is the decay correction factor.

Assessment of Local Blood Volume

During the collection of the blood volume scan, some of the 11CO absorbed by the red blood cells is released and washed out at a slow rate. To account for this effect, two arterial blood samples are withdrawn, one at the beginning of the image collection and one at the end. Assuming a monoexponential 11CO washout, its time constant &tgr;<SUB><A><AC>V</AC><AC>·</AC></A></SUB>b can be calculated as
&tgr;<SUB><A><AC>V</AC><AC>·</AC></A> b</SUB> = T<SUB>b</SUB>/ln <FR><NU>C<SUB>CO<SUB>1</SUB></SUB></NU><DE>C<SUB>CO<SUB>2</SUB></SUB></DE></FR> (A9)
where CCO1 is mass concentration of the tracer at the beginning of the imaging; and CCO2 is mass concentration of the tracer at the end of the imaging.

The voxel count rate nb at time t is a product of the blood volume in the voxel Vb, concentration of the tracer, and a term that accounts for the radioactive decay of the tracer
<IT>n</IT><SUB>b</SUB>(<IT>t</IT>) = <IT>K</IT><SUB>cam</SUB>V<SUB>b</SUB>C<SUB>CO</SUB>(<IT>t</IT>)A<SUB>CO</SUB><IT>e</IT><SUP>−<IT>t</IT>/&tgr;<SUB><A><AC>V</AC><AC>˙</AC></A> b</SUB></SUP> (A10)
where CCO(t) is instantaneous mass tracer concentration at time t.

The total number of counts per voxel in the collected image Sb is obtained by integrating Eq. A10 over the collection time Tb.
<IT>S</IT><SUB>b</SUB> = <IT>K</IT><SUB>cam</SUB>V<SUB>a</SUB>C<SUB>CO</SUB>A<SUB>CO</SUB>T<SUB>b</SUB>/<IT>f</IT><SUB>b</SUB> (A11)
where fb = (Tb/tau e b)/(1 - e-Tb/tau eb) is a combined radioactive decay and tracer washout decay correction factor; tau e b &tgr;<SUB><A><AC>V</AC><AC>·</AC></A></SUB>btau d/(&tgr;<SUB><A><AC>V</AC><AC>·</AC></A></SUB>b + tau d) is effective time constant; Va is arterial blood volume; and CCOACO is specific activity of the blood corrected to the beginning of recording time.

Contribution of Activity in Arterial Blood Volume During the CI Protocol

The estimated counts originated from pulmonary arterial blood, values of Sb are normalized by the ratio of blood-specific activities and collection times during CI and blood volume and by assuming that a fraction fa of total lung blood volume is pulmonary arterial blood
<IT>S</IT><SUB>bn</SUB> = <SUP>2</SUP><IT>S</IT><SUB>b</SUB><IT>f</IT><SUB>gated</SUB><IT>f</IT><SUB>b</SUB><IT>f</IT><SUB>a</SUB> <FR><NU>C<SUB>pa</SUB>A<SUB>NN</SUB></NU><DE>0.9 C<SUB>CO</SUB>A<SUB>CO</SUB></DE></FR> <FR><NU>T<SUB>CI</SUB></NU><DE>T<SUB>b</SUB></DE></FR> (A12)
where fa is fraction of local arterial pulmonary blood (assumed to be 0.42); CpaANN is specific activity of 13NN in pulmonary artery blood sampled during the collection of the CI image and decay corrected to the beginning of collection of SCI; CCOACO is specific activity of 11CO in pulmonary artery taken during collection of blood volume image and decay corrected to the time of beginning of the image collection; and 0.9 is a factor in the denominator of Eq. A12 that corrects for the reduction in red blood cell content of pulmonary blood (6).


REFERENCES

1. Brudin, L. H., C. G. Rhodes, S. O. Valind, T. Jones, B. Johnson, and J. M. B. Hughes. Interrelationships between regional blood flow, blood volume, and ventilation in supine humans. J. Appl. Physiol. 76: 1205-1210, 1994. [Abstract/Free Full Text] .
2. Brudin, L. H., C. G. Rhodes, S. O. Valind, T. Jones, B. Johnson, and J. M. B. Hughes. Relationships between regional ventilation and vascular and extravascular volume in supine humans. J. Appl. Physiol. 76: 1195-1204, 1994. [Abstract/Free Full Text] .
3. Hales, C. A., B. Ahluwalia, and H. Kazemi. Strength of pulmonary vascular response to regional alveolar hypoxia. J. Appl. Physiol. 38: 1083-1087, 1975. [Abstract/Free Full Text] .
4. Mintun, M. A., M. M. Ter-Pogossian, M. A. Green, L. L. Lych, and D. P. Schuster. Quantitative measurement of regional pulmonary blood flow with positron emission tomography. J. Appl. Physiol. 60: 317-324, 1986. [Abstract/Free Full Text] .
5. Rhodes, C. G., S. O. Valind, L. H. Brudin, P. E. Wollmer, T. Jones, and J. M. B. Hughes. Quantification of regional V/Q ratios in humans by use of PET. I. Theory. J. Appl. Physiol. 66: 1896-1904, 1989. [Abstract/Free Full Text] .
6. Rhodes, C. G., S. O. Valind, L. H. Brudin, P. E. Wollmer, T. Jones, P. D. Buckingham, and J. M. B. Hughes. Quantification of regional V/Q ratios in humans by use of PET. II. Procedure and normal values. J. Appl. Physiol. 66: 1905-1913, 1989. [Abstract/Free Full Text] .
7. Schuster, D. P. Positron emission tomography: theory and its application to the study of lung disease. Am. Rev. Respir. Dis. 139: 818-840, 1989. [Medline] .
8. Seow, D., C. Andrie, A. Head, and J. Venegas. Assessment of intrapulmonary perfusion (Q) and shunt (Qs) with positron emission tomography (Abstract). Am. J. Respir. Crit. Care Med. 151, Suppl. 4, pt. 2: A520, 1995.
9. Treppo, S., S. M. Mijailovich, and J. G. Venegas. Contributions of pulmonary perfusion and ventilation to heterogeneity in VA/Q measured by PET. J. Appl. Physiol. 82: 1163-1176, 1997. [Abstract/Free Full Text] .
10. Tsuzaki, K., S. C. A. Hales, D. J. Strieder, and J. G. Venegas. Regional lung mechanics and gas transport in lungs with inhomogenous compliance. J. Appl. Physiol. 75: 206-216, 1993. [Abstract/Free Full Text] .
11. Valind, S. O., P. E. Wollmer, and C. G. Rhodes. Application of positron emission tomography in the lung. In: Positron Emission Tomography, edited by M. Reivich, and A. Alavi. New York: Liss, 1995, p. 387-412. .
12. Venegas, J. G., S. Treppo, and S. M. Mijailovich. Contributions of statistical noise to spatial heterogeneity of PET images of pulmonary function. In: Medical Imaging 1994: Physiology and Function from Multidimensional Images (Proceedings), edited by E. A. Hofman, and R. S. Acharya. Newport Beach, CA: SPIE-T Int. Soc. for Optical Engineering, 1994, vol. 2168, p. 361-368. .
13. Venegas, J. G., Y. Yamada, C. Burnham, and C. A. Hales. Local gas transport in eucapnic ventilation: effects of gravity and breathing frequency. J. Appl. Physiol. 68: 2287-2295, 1990. [Abstract/Free Full Text] .
14. Venegas, J. G., Y. Yamada, J. Custer, and C. A. Hales. Effect of respiratory variables on regional gas transport during high-frequency ventilation. J. Appl. Physiol. 64: 2108-2118, 1988. [Abstract/Free Full Text] .
15. Yamada, Y., C. Burnham, C. A. Hales, and J. G. Venegas. Regional mapping of gas transport during high-frequency and conventional ventilation. J. Appl. Physiol. 66: 1209-1218, 1989. [Abstract/Free Full Text] .

0161-7567/97 $5.00 Copyright © 1997 the American Physiological Society



This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
G. Musch, G. Bellani, M. F. Vidal Melo, R. S. Harris, T. Winkler, T. Schroeder, and J. G. Venegas
Relation between Shunt, Aeration, and Perfusion in Experimental Acute Lung Injury
Am. J. Respir. Crit. Care Med., February 1, 2008; 177(3): 292 - 300.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
T. Schroeder, M. F. Vidal Melo, G. Musch, R. S. Harris, T. Winkler, and J. G. Venegas
PET Imaging of Regional 18F-FDG Upta